3,4-methylenedioxyamphetamine and Anemia, Hemolytic, Acquired

3,4-methylenedioxyamphetamine has been researched along with Anemia, Hemolytic, Acquired in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Woodrow, G	1
Harnden, P	1
Turney, JH	1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Anemia, Hemolytic, Acquired

Article	Year
Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Pressure; Brain	1995

Article

Year

Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:3

Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Pressure; Brain

1995